ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

5 links0 made here, not in the record9 judgments2 judges (the rules as one: Rule based)1 record change seen
Claude Opus 5.5Rule basedRecord updated on ClinicalTrials.gov
Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT07905924A Study to Evaluate theSafety and Effectiveness ofDifferent Doses ofRO7836748 Alone or inCombination With OtherCancer Therapies in PeopleWith Solid Tumors With aHoffmann-La RochePhase 1 · not yet recruitingRECORDThe record itselfVersions seen nightly since Sep 25, 2…›Oct 30 · ClinicalTrials.gov record · Version of 2026-10-30Version of 2026-10-30CONDITIONSSolid TumorsNo longer in the registry's filing›Nov 14 · Rule based · General: a category, not a diseaseGeneral: a category, not a diseaseDRUGSINT035541Entry “RO7836748”, read by our name r…›Nov 1 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedPembrolizumabIntervention entry›Nov 1 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · BackgroundBackgroundINT010129Entry “mFOLFIRINOX”, read by our name…›Nov 1 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · BackgroundBackgroundCetuximabIntervention entry›Nov 1 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · BackgroundBackground

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

INT035541

From the registry record2 judgments on this link
Role in the study, from the registry to what was judged
RegistryEntry “RO7836748”the record gives no role
→judged=agrees
How the 2 judgments split100%of judgments with a known value say Tested
Tested · 2

All judgments on this study

WhenLinkJudgeDecisionState
Oct 30The record itselfClinicalTrials.gov recordVersion of 2026-10-30Record change
Nov 1INT035541Claude Opus 5.5TestedCurrent
Nov 1PembrolizumabClaude Opus 5.5BackgroundCurrent
Nov 1INT010129Claude Opus 5.5BackgroundCurrent
Nov 1CetuximabClaude Opus 5.5BackgroundCurrent
Nov 14Solid TumorsRule based · condition-kind ruleGeneral: a category, not a diseaseCurrent
Nov 18INT035541Rule based · role ruleTestedAgrees
Nov 18PembrolizumabRule based · role ruleBackgroundAgrees
Nov 18INT010129Rule based · role ruleBackgroundAgrees
Nov 18CetuximabRule based · role ruleBackgroundAgrees

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

Which drugs a study tests

Reads each treatment the study lists and the arms it is in. A drug only in the experimental arm is tested. A drug in every arm while something else changes between the arms is given beside it. A drug only in the control arm is the comparator. Placebo, procedures and usual care are known by name.

Where the whole record has been read, that reading's answer replaces the rule's.

How a condition link is counted

For each condition a study is filed under: whether it is the study's own condition at the finest the study states it, a wider one, a general category, or filed by mistake; and whether it is the main condition, a setting the study names, or only how it was filed.

A decision on file for one study overrides it, with who made it and when.